Frontiers in Pharmacology, 2016 · DOI: 10.3389/fphar.2016.00047 · Published: March 8, 2016
Spinal cord injury (SCI) stimulates activation of astrocytes and infiltration of immune cells at the lesion site. The study explores the neuroregenerative properties of co-ultraPEALut in a murine model of SCI. Mice were treated with co-ultraPEALut (1 mg/kg, intraperitoneally) daily for 72 h after SCI. The treatment increased the numbers of bromodeoxyuridine-positive nuclei and doublecortin-immunoreactive cells. Co-ultraPEALut administration stimulated expression of the neurotrophic factors brain-derived neurotrophic factor, glial cell-derived neurotrophic factor, nerve growth factor, and neurotrophin-3. These findings show a prominent effect of co-ultraPEALut administration in the management of survival and differentiation of new neurons and spine maturation.
Co-ultraPEALut may be a novel therapeutic approach for treating spinal cord injury.
The study suggests that co-ultraPEALut can promote neuroregeneration after SCI.
The composite was administered after trauma, simulating the clinical condition, suggesting clinical relevance.